{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:16:29Z","timestamp":1793304989575,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19206"],"award-info":[{"award-number":["19206"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Research UK\/AIRC\/FC-AECC","award":["C69358\/A29365"],"award-info":[{"award-number":["C69358\/A29365"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1245\/s10434-022-12367-6","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T13:17:56Z","timestamp":1662988676000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes"],"prefix":"10.1245","volume":"30","author":[{"given":"Dario","family":"Baratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-9810","authenticated-orcid":false,"given":"Marcello","family":"Guaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Milione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pietrantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Cavalleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"12367_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","volume":"28","author":"TDJH Patrick-Brown","year":"2021","unstructured":"Patrick-Brown TDJH, Carr NJ, Swanson DM, Larsen SG, Mohammed F, Flatmark K. Estimating the prevalence of pseudomyxoma peritonei in Europe using a novel statistical method. Ann Surg Oncol. 2021;28:252\u20137. https:\/\/doi.org\/10.1245\/s10434-020-08655-8.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR2","first-page":"100","volume":"84","author":"R Werth","year":"1884","unstructured":"Werth R. Klinische and Anastomische Untersuchungen Zur Lehre von der Bauchgeswullsten und der laparotomy. Arch Gynecol Obstet. 1884;84:100\u201318.","journal-title":"Arch Gynecol Obstet."},{"key":"12367_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33:511\u20139.","journal-title":"Int J Hyperthermia."},{"key":"12367_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A Consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40:14.","journal-title":"Am J Surg Pathol"},{"key":"12367_CR5","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1245\/s10434-016-5350-9","volume":"23","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Milione M, et al. Pseudomyxoma peritonei of extra-appendiceal origin: a comparative study. Ann Surg Oncol. 2016;23:4222\u201330. https:\/\/doi.org\/10.1245\/s10434-016-5350-9.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331. https:\/\/doi.org\/10.1007\/s10434-999-0727-7.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","volume":"30","author":"RF Bradley","year":"2006","unstructured":"Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30:551\u20139.","journal-title":"Am J Surg Pathol."},{"key":"12367_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","volume":"249","author":"D Baratti","year":"2009","unstructured":"Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2009;249:243\u20139.","journal-title":"Ann Surg."},{"key":"12367_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456\u201362.","journal-title":"Eur J Surg Oncol."},{"key":"12367_CR10","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."},{"key":"12367_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/jso.23679","volume":"110","author":"J Esquivel","year":"2014","unstructured":"Esquivel J, Garcia SS, Hicken W, et al. Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. J Surg Oncol. 2014;110:656\u201360.","journal-title":"J Surg Oncol."},{"key":"12367_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, et al. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis. 2015;17:772\u20138.","journal-title":"Colorectal Dis."},{"key":"12367_CR13","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1245\/s10434-015-5047-5","volume":"23","author":"V Milovanov","year":"2016","unstructured":"Milovanov V, Sardi A, Studeman K, et al. The 7th edition of the AJCC staging classification correlates with biologic behavior of mucinous appendiceal tumor with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). Ann Surg Oncol. 2016;23:1928\u201333. https:\/\/doi.org\/10.1245\/s10434-015-5047-5.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1245\/s10434-017-6214-7","volume":"25","author":"HA Choudry","year":"2018","unstructured":"Choudry HA, Pai RK, Shuai Y, et al. Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei. Ann Surg Oncol. 2018;25:76\u201382. https:\/\/doi.org\/10.1245\/s10434-017-6214-7.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","volume":"219","author":"DB Gough","year":"1994","unstructured":"Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994;219:112\u20139.","journal-title":"Ann Surg."},{"key":"12367_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1463-1318.2009.01947.x","volume":"12","author":"P J\u00e4rvinen","year":"2010","unstructured":"J\u00e4rvinen P, J\u00e4rvinen HJ, Lepist\u00f6 A. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis. 2010;12:868\u201372.","journal-title":"Colorectal Dis."},{"key":"12367_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1245\/s10434-006-9174-x","volume":"14","author":"RM Smeenk","year":"2006","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Frans AN, Zoetmulder FAN. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol. 2006;14:493\u20139. https:\/\/doi.org\/10.1245\/s10434-006-9174-x.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR18","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14:2289\u201399. https:\/\/doi.org\/10.1245\/s10434-007-9462-0.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejso.2016.08.021","volume":"43","author":"JB Delhorme","year":"2017","unstructured":"Delhorme JB, Honor\u00e9 C, Benhaim L, et al. Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. Eur J Surg Oncol. 2017;43:159\u201367. https:\/\/doi.org\/10.1016\/j.ejso.2016.08.021.","journal-title":"Eur J Surg Oncol."},{"key":"12367_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/bjs5.97","volume":"3","author":"F Mercier","year":"2018","unstructured":"Mercier F, Dagbert F, Pocard M, et al. Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open. 2018;3:195\u2013202. https:\/\/doi.org\/10.1002\/bjs5.97.","journal-title":"BJS Open."},{"key":"12367_CR21","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","volume":"28","author":"N Ahmadi","year":"2021","unstructured":"Ahmadi N, Kostadinov D, Sakata S, et al. Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons. Ann Surg Oncol. 2021;28:7809\u201320.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1245\/s10434-019-07678-0","volume":"27","author":"D Solomon","year":"2020","unstructured":"Solomon D, Bekhor E, Leigh N, et al. Surveillance of low-grade appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: are 5 years enough? A multisite experience. Ann Surg Oncol. 2020;27:147\u201353.","journal-title":"Ann Surg Oncol"},{"key":"12367_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF02523654","volume":"7","author":"SR Pestieau","year":"2000","unstructured":"Pestieau SR, Esquivel J, Sugarbaker PH. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol. 2000;7:199\u2013203. https:\/\/doi.org\/10.1007\/BF02523654.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jso.21230","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Yap ZL, et al. Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. J Surg Oncol. 2009;99:292\u20135. https:\/\/doi.org\/10.1002\/jso.21230.","journal-title":"J Surg Oncol."},{"key":"12367_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1309\/601K2L2T7CR5U7G1","volume":"127","author":"KR Geisinger","year":"2007","unstructured":"Geisinger KR, Levine EA, Shen P, Bradley RF. Pleuropulmonary involvement in pseudomyxoma peritonei. Morphologic assessment and literature review. Am J Clin Pathol. 2007;127:135\u201343.","journal-title":"Am J Clin Pathol."},{"key":"12367_CR26","doi-asserted-by":"publisher","first-page":"690256","DOI":"10.1155\/2012\/690256","volume":"2012","author":"T Kitai","year":"2012","unstructured":"Kitai T. Pulmonary metastasis from pseudomyxoma peritonei. Gastroenterol Res Pract. 2012;2012:690256.","journal-title":"Gastroenterol Res Pract"},{"key":"12367_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/030089160609200204","volume":"92","author":"J Cabanas","year":"2006","unstructured":"Cabanas J, Gomes da Silva R, Zappa L. Splenic metastases from mucinous neoplasms of the appendix and colon. Tumori. 2006;92:104\u201312.","journal-title":"Tumori."},{"key":"12367_CR28","first-page":"108","volume":"7","author":"R D\u2019Alpino Peixoto","year":"2014","unstructured":"D\u2019Alpino Peixoto R, Wilson S, Schaeffer DF, Lim HJ. Pseudomyxoma peritonei metastatic to the bone: case report and review of systemic management. Gastrointest Cancer Res. 2014;7:108\u201310.","journal-title":"Gastrointest Cancer Res."},{"key":"12367_CR29","unstructured":"WHO Classification of Tumours: Digestive system tumours. 5th Ed. WHO Classification of Tumours Editorial Board (ed). Lyon: International Agency for Research on Cancer; 2019."},{"key":"12367_CR30","first-page":"49","volume":"15","author":"P Jaquet","year":"1996","unstructured":"Jaquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"12367_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jso.21388","volume":"100","author":"M Deraco","year":"2009","unstructured":"Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100:321\u20138.","journal-title":"J Surg Oncol."},{"key":"12367_CR32","unstructured":"National Cancer Institute, Division of Cancer Treatment and Diagnosis. Common Terminology Criteria for Adverse Events (CTCAE). Available at https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"issue":"7","key":"12367_CR33","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ejso.2022.01.010","volume":"48","author":"D Baratti","year":"2022","unstructured":"Baratti D, Milito P, Kusamura S, Martin Roman L, Guaglio M, Deraco M. Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: treatments and outcomes. Eur J Surg Oncol. 2022;48(7):1590\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"12367_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1634\/theoncologist.2014-0106","volume":"19","author":"F Pietrantonio","year":"2014","unstructured":"Pietrantonio F, Maggi C, Fanetti G, et al. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist. 2014;19:845\u201350.","journal-title":"Oncologist."},{"issue":"14","key":"12367_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12967-016-0877-x","volume":"6","author":"F Pietrantonio","year":"2016","unstructured":"Pietrantonio F, Berenato R, Maggi C, et al. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. J Transl Med. 2016;6(14):125.","journal-title":"J Transl Med."},{"key":"12367_CR36","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.clcc.2019.03.002","volume":"18","author":"A Raimondi","year":"2019","unstructured":"Raimondi A, Corallo S, Niger M, et al. Metronomic capecitabine with cyclophosphamide regimen in unresectable or relapsed pseudomyxoma peritonei. Clin Colorectal Cancer. 2019;18:e179\u201390.","journal-title":"Clin Colorectal Cancer."},{"key":"12367_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Zaidi MY, Lee RM, et al. Optimal Surveillance frequency after CRS\/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020;27:134\u201346.","journal-title":"Ann Surg Oncol."},{"key":"12367_CR38","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","volume":"27","author":"F Pietrantonio","year":"2016","unstructured":"Pietrantonio F, Perrone F, Mennitto A, et al. Toward the molecular dissection of peritoneal pseudomyxoma. Ann Oncol. 2016;27:2097\u2013103.","journal-title":"Ann Oncol."},{"key":"12367_CR39","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.3390\/cancers13235965","volume":"13","author":"A Sommariva","year":"2021","unstructured":"Sommariva A, Tonello M, Rigotto G, Lazzari N, Pilati P, Calabr\u00f2 ML. Novel perspectives in pseudomyxoma peritonei treatment. Cancers (Basel). 2021;13:5965.","journal-title":"Cancers (Basel)."},{"key":"12367_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jso.26702","volume":"125","author":"LG Campana","year":"2022","unstructured":"Campana LG, Wilson MS, Halstead R, Wild J, O\u2019Dwyer ST. The need for tailored posttreatment surveillance for low-grade appendiceal mucinous neoplasms (LAMN). J Surg Oncol. 2022;125:317\u20139.","journal-title":"J Surg Oncol."},{"key":"12367_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ejso.2013.08.017","volume":"39","author":"A Sardi","year":"2013","unstructured":"Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39:1207\u201313.","journal-title":"Eur J Surg Oncol."},{"key":"12367_CR42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/bjs5.50262","volume":"4","author":"JB Karpes","year":"2020","unstructured":"Karpes JB, Lansom JD, Alshahrani M, et al. Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms. BJS Open. 2020;4:478\u201385.","journal-title":"BJS Open."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12367-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12367-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12367-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:22:20Z","timestamp":1670347340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12367-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["12367"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12367-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"10 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}